Загрузка...
Sofosbuvir as a potential alternative to treat the SARS-CoV-2 epidemic
As of today, there is no antiviral for the treatment of the SARS-CoV-2 infection, and the development of a vaccine might take several months or even years. The structural superposition of the hepatitis C virus polymerase bound to sofosbuvir, a nucleoside analog antiviral approved for hepatitis C vir...
Сохранить в:
| Опубликовано в: : | Sci Rep |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Nature Publishing Group UK
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7283245/ https://ncbi.nlm.nih.gov/pubmed/32518317 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-66440-9 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|